American Vanguard heads into its May 29 earnings report carrying an odd tension: the stock has recovered sharply from its lows, yet short sellers have spent the past month quietly rebuilding positions at the fastest pace of the past year.
The short interest story is the most striking data point right now. SI % of float has jumped from roughly 2.4% in mid-March to 4.0% by April 28 — a 65% increase over the past month. That move came in two clear steps: a gradual drift higher through early April, followed by a sharper leg up around April 23 as shorts added more meaningfully. The week itself saw an 8% week-on-week increase in shares short, even as the stock posted a 3.3% weekly gain. Shorts are adding into strength.
The lending market, though, is nowhere near stressed. Availability remains loose — cost to borrow is running at just 0.82% annualised, well below where it was in late March and early April when it touched 1.4–1.6%. That's not the footprint of a hard-to-borrow name or an impending squeeze; it's a stock that's easy and cheap to short, which may partly explain why positioning has crept higher without any noticeable squeeze pressure. Options confirm the cautious but not alarmed tone: the put/call ratio at 0.34 is modestly above its 20-day average of 0.33, a z-score of just 1.2 — slightly more defensive than the recent norm, but nothing that signals conviction.
The Street angle is complicated by stale data. The most recent analyst action on record is a June 2025 target cut by Lake Street, which trimmed its Buy price target from $14 to $12. With AVD now trading at $2.85, a target of $12 represents a theoretical 320% upside — a figure that reflects the stock's deterioration since that note was filed, not a live view of value. Treat existing targets as outdated rather than actionable. The ORTEX short score of 37.3 sits in the lower third of its recent range, while the sector score and analyst rec differential both rank at the 50th percentile — a broadly neutral positioning read with nothing extreme in either direction.
Institutional ownership tells a more constructive story, at least as of the last filings. BlackRock added 235,000 shares in Q1, bringing its stake to 6.6% of the company. EVR Research, a smaller active manager, built a 278,000-share position in Q4. Potomac Capital is a notable new entrant, filing a full 458,000-share position initiated in the second half of 2025. Against that, Cruiser Capital — a long-time holder — trimmed by 217,000 shares. On balance, institutions were net buyers in recent quarters even as the stock was declining.
The earnings history adds the sharpest edge to this setup. The March 2026 quarterly print produced a 14% one-day loss and a 40% five-day loss. The prior event delivered a 22% single-day drop. Back-to-back prints of that magnitude have left the stock down roughly 60% from its 2024 highs, which explains why short sellers may feel comfortable pressing even at sub-$3 levels. The next print, confirmed for May 29, is the clearest near-term catalyst — and the question heading into it is whether the cost structure has stabilised enough to interrupt that pattern of downside surprises.
See the live data behind this article on ORTEX.
Open AVD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
